AT336793B - Verfahren zur herstellung von wasserigen oxytetracyclinlosungen zur parenteralen, peroralen und lokalen anwendung - Google Patents

Verfahren zur herstellung von wasserigen oxytetracyclinlosungen zur parenteralen, peroralen und lokalen anwendung

Info

Publication number
AT336793B
AT336793B AT119375A AT119375A AT336793B AT 336793 B AT336793 B AT 336793B AT 119375 A AT119375 A AT 119375A AT 119375 A AT119375 A AT 119375A AT 336793 B AT336793 B AT 336793B
Authority
AT
Austria
Prior art keywords
oxytetracyclin
peroral
aquatic
parenteral
solutions
Prior art date
Application number
AT119375A
Other languages
English (en)
Other versions
ATA119375A (de
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of ATA119375A publication Critical patent/ATA119375A/de
Application granted granted Critical
Publication of AT336793B publication Critical patent/AT336793B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT119375A 1974-02-19 1975-02-18 Verfahren zur herstellung von wasserigen oxytetracyclinlosungen zur parenteralen, peroralen und lokalen anwendung AT336793B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH227674 1974-02-19

Publications (2)

Publication Number Publication Date
ATA119375A ATA119375A (de) 1976-09-15
AT336793B true AT336793B (de) 1977-05-25

Family

ID=4229973

Family Applications (1)

Application Number Title Priority Date Filing Date
AT119375A AT336793B (de) 1974-02-19 1975-02-18 Verfahren zur herstellung von wasserigen oxytetracyclinlosungen zur parenteralen, peroralen und lokalen anwendung

Country Status (17)

Country Link
US (1) US4020162A (de)
JP (1) JPS50129724A (de)
AT (1) AT336793B (de)
BE (1) BE825656A (de)
CA (1) CA1052270A (de)
DE (1) DE2506579A1 (de)
DK (1) DK138974B (de)
ES (1) ES434805A1 (de)
FR (1) FR2261011B1 (de)
GB (1) GB1494558A (de)
IE (1) IE40663B1 (de)
LU (1) LU71862A1 (de)
MX (1) MX3044E (de)
NL (1) NL7501248A (de)
PH (1) PH11892A (de)
SE (1) SE434457B (de)
ZA (1) ZA751016B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4018889A (en) * 1976-01-02 1977-04-19 Pfizer Inc. Oxytetracycline compositions
JPS61501566A (ja) * 1984-03-14 1986-07-31 コルビエ−ル　ジエロ−ム 有効成分の可溶化法およびそれにより得られる薬理組成物
JPS61130228A (ja) * 1984-11-29 1986-06-18 Sunstar Inc ミノサイクリンを安定に配合した組成物
DE3623620A1 (de) * 1986-07-12 1988-01-21 Boehringer Mannheim Gmbh Spritzfertige, waessrige, alkalische injektionsloesungen von torasemid und verfahren zu ihrer herstellung
US5075295A (en) * 1989-12-12 1991-12-24 Boehringer Ingelheim Animal Health, Inc. Novel oxytetracycline compositions
ES2130069B1 (es) * 1997-04-10 2000-03-01 Basf Labiana S A Preparacion farmaceutica con liberacion retardada del producto activo.
US20020077276A1 (en) * 1999-04-27 2002-06-20 Fredeking Terry M. Compositions and methods for treating hemorrhagic virus infections and other disorders
US20090035260A1 (en) * 2002-07-29 2009-02-05 Therapicon Srl Enhanced nasal composition of active peptide
ITMI20040235A1 (it) * 2004-02-13 2004-05-13 Therapicon Srl Preparazione farmaceutica per il cavo orale
WO2006130599A2 (en) * 2005-05-31 2006-12-07 Warsaw Orthopedic, Inc. Compositions and methods for treating a damaged cardiovascular element
US8840933B2 (en) 2006-05-03 2014-09-23 Warsaw Orthopedic, Inc. Method of treating neuronal injury by administering magnesium chloride and PEG
US8945623B2 (en) * 2006-05-03 2015-02-03 Warsaw Orthopedic, Inc. Compositions comprising biomembrane sealing agent for treatment of neuronal injury, and methods of use
US8057458B2 (en) * 2006-10-30 2011-11-15 Warsaw Orthopedic, Inc. Method for treating facet pain
US9675696B2 (en) * 2006-11-14 2017-06-13 Warsaw Orthopedic, Inc. Method and use for increasing efficacy of anti-adhesive compositions in controlling inflammation and pain
US8153112B2 (en) * 2007-08-03 2012-04-10 Warsaw Orthopedic, Inc. Compositions and methods for treating cavity conditions
US8852566B2 (en) * 2009-03-26 2014-10-07 Warsaw Orthopedic, Inc. Compositions and methods for preferential distribution of active agents to injury sites
US9244060B2 (en) * 2009-03-26 2016-01-26 Warsaw Orthopedic, Inc. Site localization and methods for monitoring treatment of disturbed blood vessels
US9078808B2 (en) * 2009-03-26 2015-07-14 Warsaw Orthopedic, Inc. Device to deliver magnesium in PEG formulation
US8858924B2 (en) 2009-03-26 2014-10-14 Warsaw Orthopedic, Inc. Compositions and methods for treatment of hemorrhage
WO2010111212A1 (en) * 2009-03-26 2010-09-30 Warsaw Orthopedic, Inc. Methods of identifying potential components for targeted drug delivery compositions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2699054A (en) * 1953-10-09 1955-01-11 Lloyd H Conover Tetracycline
US3017323A (en) * 1957-07-02 1962-01-16 Pfizer & Co C Therapeutic compositions comprising polyhydric alcohol solutions of tetracycline-type antibiotics

Also Published As

Publication number Publication date
BE825656A (fr) 1975-08-18
MX3044E (es) 1980-03-04
DE2506579A1 (de) 1975-08-21
IE40663L (en) 1975-08-19
DK138974B (da) 1978-11-27
GB1494558A (en) 1977-12-07
LU71862A1 (de) 1975-12-09
ATA119375A (de) 1976-09-15
ZA751016B (en) 1976-01-28
IE40663B1 (en) 1979-07-18
PH11892A (en) 1978-08-29
JPS50129724A (de) 1975-10-14
AU7830775A (en) 1976-08-19
DK4375A (de) 1975-10-20
SE434457B (sv) 1984-07-30
CA1052270A (en) 1979-04-10
FR2261011A1 (de) 1975-09-12
FR2261011B1 (de) 1978-07-21
ES434805A1 (es) 1976-12-01
DK138974C (de) 1979-05-07
NL7501248A (nl) 1975-08-21
US4020162A (en) 1977-04-26

Similar Documents

Publication Publication Date Title
AT336793B (de) Verfahren zur herstellung von wasserigen oxytetracyclinlosungen zur parenteralen, peroralen und lokalen anwendung
DD127731A5 (de) Verfahren zur herstellung von cephalosporansaeurederivaten
ATA966275A (de) Verfahren zur herstellung von p-benzochinondiketalen
ATA599875A (de) Verfahren zur herstellung von athylen-butadien-copolymeren
AT343802B (de) Verfahren zur herstellung von derivaten von 4,6-di-0- (aminoglycosyl)-2-deoxystreptaminen
AT333774B (de) Verfahren zur herstellung von 3-phenylpyridazonen
ATA731275A (de) Verfahren zur herstellung von 3,4-dihydro-2h-1,2-benzothiazin-1,1-dioxiden
ATA904575A (de) Verfahren zur herstellung von neuen 1,3-dialkyl-7-aminoalkylxanthinen
AT333749B (de) Verfahren zur herstellung von neuen 2-arylamino-2-imidazolinderivaten
ATA179075A (de) Verfahren zur herstellung von s-triazolo-(3,4-b)benzothiazolen
DD122962A5 (de) Verfahren zur herstellung von halogenanthrachinonen
AT341672B (de) Verfahren zur herstellung von 3-methylencephamsulfoxiden
AT343120B (de) Verfahren zur herstellung von 6-chlor-2-chlormethyl-4-phenylchinazolin-3-oxid
AT339280B (de) Verfahren zur herstellung von phloroglucin
AT342030B (de) Verfahren zur herstellung von neuen 1-benzoyloxyphenyl-2-aminoathanolen- (1)
DD129786A5 (de) Verfahren zur herstellung von neuen pyridazinderivaten
AT346340B (de) Verfahren zur herstellung von 2-halogenmethyl- 1,4-benzodiazepinen
DD122986A1 (de) Verfahren zur herstellung von polyesteralkoholen
AT350199B (de) Verfahren zur herstellung von 17-monoestern von 17alfa,21-dihydroxysteroiden
AT344675B (de) Verfahren zur herstellung von 3-fluor-dl-alanin
AT335063B (de) Verfahren zur herstellung von d(-)-alfa-amino-p-hydroxybenzylpenicillin
DD122973A5 (de) Verfahren zur herstellung von 4a-aryl-transdecahydroisochinolinen
AT340415B (de) Verfahren zur herstellung von neuen anhydro-2-mercapto-1,3,4-thiadiazoliumhydroxiden
AT334336B (de) Verfahren zur herstellung von 1-phenyl -2- glycinamidoathanolen-(1)
DD128735A5 (de) Verfahren zur herstellung von 3-cyanopenamen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee
UEP Publication of translation of european patent specification